LENZ Therapeutics, Inc. (LENZ)
Nasdaq: LENZ · Biological Products, (No Diagnostic Substances) · Solana Beach, CA · filing with the SEC since 2021
Who owns LENZ Therapeutics, Inc.
As filed with the SECHolders of 5% or more
5
RA Capital Management, L.P. holds 13.6% of Common Stock, $0.00001 par value per share, as its SCHEDULE 13D/A filed Nov 7, 2025 says.
Directors and officers
15
report now, of 28 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
RA Capital Management, L.P.
SCHEDULE 13D/A · filed Nov 7, 2025 · Common Stock, $0.00001 par value per share · 15.1% in May 9, 2025
Blackrock, Inc.
SCHEDULE 13G · filed Apr 27, 2026 · Common Stock · 4.9% in Jan 21, 2026
Fmr LLC
SCHEDULE 13G/A · filed Sep 8, 2026 · COMMON STOCK · 11.8% in Feb 5, 2026
BlackRock Portfolio Management LLC
SCHEDULE 13G · filed Oct 27, 2026 · Common Stock
Squarepoint Ops LLC
SCHEDULE 13G · filed Apr 8, 2026 · Common Stock
Steven A. Cohen
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.00001 per share · reported falling below 5%
Paradigm BioCapital Advisors LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, $0.00001 par value per share · reported falling below 5%, from 5.2% in Mar 27, 2025
Millennium Management LLC
SCHEDULE 13G/A · filed Oct 21, 2026 · Common Stock, par value $0.00001 per share · reported falling below 5%, from 5.1% in Jun 26, 2026
Versant Venture Capital VI, L.P.
SCHEDULE 13D/A · filed Nov 10, 2025 · Common Stock, par value $0.00001 per share · reported falling below 5%, from 4.1% in Sep 22, 2025
Ridgeback Capital Investments L.P.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.00001 per share · reported falling below 5%
What LENZ reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 24, 2026.
Insider tradesForm 4
5sales
6purchases
2sales on a scheduled plan
2people selling
$9.4Msold, in dollars
$700,000bought, in dollars
Open-market trades on Form 4 from Nov 3, 2025 to Nov 3, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 3, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 45 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | director | 3 | $9.1M | 0 | 0 | $0 |
| Olsson Shawn | Chief Commercial Officer | 2 | $300,000 | 2 | 0 | $0 |
| Chevallard Daniel R. | Chief Financial Officer | 0 | $0 | 0 | 3 | $100,000 |
| Schimmelpennink Evert B. | President, CEO and Secretary | 0 | $0 | 0 | 1 | $300,000 |
| George Jeffrey P. | director | 0 | $0 | 0 | 1 | $0 |
| Mccollum James W | director | 0 | $0 | 0 | 1 | $200,000 |